{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:03Z","timestamp":1786118883242,"version":"build-2736575974"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/bor.0b013e3282f05c6d","type":"journal-article","created":{"date-parts":[[2007,10,4]],"date-time":"2007-10-04T03:01:09Z","timestamp":1191466869000},"page":"626-635","source":"Crossref","is-referenced-by-count":12,"title":["Targets of anticytokine therapy and the risk of infections in humans and mice"],"prefix":"10.1097","volume":"19","author":[{"given":"Esther","family":"van de Vosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel A","family":"van Agtmael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210128","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R2-17-20210128","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/art.21249","article-title":"Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study","volume":"52","author":"Baslund","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R3-17-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/030097401316909530","article-title":"Randomized, double-blind trial of antiinterferon-gamma antibodies in rheumatoid arthritis","volume":"30","author":"Sigidin","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"R4-17-20210128","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa033402","article-title":"Antiinterleukin-12 antibody for active Crohn's disease","volume":"351","author":"Mannon","year":"2004","journal-title":"N Engl J Med"},{"key":"R5-17-20210128","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1469-0691.2006.01546.x","article-title":"Role of antitumour necrosis factor-alpha therapeutic agents in the emergence of infections","volume":"12","author":"Moiton","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R6-17-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Furst","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"R7-17-20210128","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/00365540410019598","article-title":"A case of legionellosis during treatment with a TNF\u03b1 antagonist","volume":"36","author":"Wondergem","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"R8-17-20210128","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1086\/508538","article-title":"Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-\u03b1 antagonists","volume":"43","author":"Tubach","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R9-17-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.diagmicrobio.2005.06.006","article-title":"Mycobacterium abscessus infection after use of tumor necrosis factor a inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor \u03b1 inhibitor use","volume":"53","author":"Mufti","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R10-17-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/00365540600786549","article-title":"Fatal Salmonella enteritidis septicaemia in a rheumatoid arthritis patient treated with a TNF-\u03b1 antagonist","volume":"39","author":"Rijkeboer","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"R11-17-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/RHU.0b013e3180690933","article-title":"Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-\u03b1 therapy","volume":"13","author":"Krishnamurthy","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"R12-17-20210128","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1086\/515402","article-title":"Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis","volume":"44","author":"Geraghty","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R13-17-20210128","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"R14-17-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00063030-200216040-00005","article-title":"Anakinra","volume":"16","author":"Cvetkovic","year":"2002","journal-title":"Biodrugs"},{"key":"R15-17-20210128","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/ard.2005.048371","article-title":"Safety of extended treatment with anakinra in patients with rheumatoid arthritis","volume":"65","author":"Fleischmann","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R16-17-20210128","first-page":"119","article-title":"Visceral leishmaniasis in a patient with systemic juvenile arthritis treated by IL-1RA agonist (Anakinra)","volume":"25","author":"Kone-Paut","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R17-17-20210128","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M","article-title":"Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis","volume":"43","author":"Bendele","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R18-17-20210128","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/PL00000629","article-title":"Antiinterleukin-1 and antitumor necrosis factor-\u03b1 synergistically inhibit adjuvant arthritis in Lewis rats","volume":"57","author":"Feige","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"R19-17-20210128","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/art.20221","article-title":"Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate","volume":"50","author":"Genovese","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R20-17-20210128","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/ard.2006.054197","article-title":"Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised antiinterleukin-6 receptor monoclonal antibody","volume":"65","author":"Ogawa","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R21-17-20210128","doi-asserted-by":"crossref","first-page":"iv24","DOI":"10.1136\/ard.2005.042531","article-title":"Immunological control of tuberculosis: role of tumour necrosis factor and more","volume":"64","author":"Stenger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R22-17-20210128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1359-6101(03)00022-4","article-title":"Biological functions of tumor necrosis factor cytokines and their receptors","volume":"14","author":"Pfeffer","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"R23-17-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405009749","article-title":"The tumour necrosis factor receptor-associated periodic syndrome: current concepts","volume":"7","author":"Stojanov","year":"2005","journal-title":"Expert Rev Mol Med"},{"key":"R24-17-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/jir.2006.0129","article-title":"Polymorphisms in pro-inflammatory genes and susceptibility to typhoid fever and paratyphoid fever","volume":"27","author":"Ali","year":"2007","journal-title":"J Interferon Cytokine Res"},{"key":"R25-17-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humimm.2006.10.011","article-title":"Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis","volume":"68","author":"Sainz","year":"2007","journal-title":"Hum Immunol"},{"key":"R26-17-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/humu.20299","article-title":"Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer","volume":"27","author":"Chakravorty","year":"2007","journal-title":"Hum Mutat"},{"key":"R27-17-20210128","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3748\/wjg.v12.i5.776","article-title":"Interleukin-1\u03b2 gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection","volume":"12","author":"Hirankarn","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R28-17-20210128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/gut.2006.113258","article-title":"Association between Helicobacter pylori infection and interleukin 1\u03b2 polymorphism predispose to CpG island methylation in gastric cancer","volume":"56","author":"Chan","year":"2007","journal-title":"Gut"},{"key":"R29-17-20210128","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/503363","article-title":"Endogenous interleukin (IL)-1\u03b1 and IL-1\u03b2 are crucial for host defense against disseminated candidiasis","volume":"193","author":"Vonk","year":"2006","journal-title":"J Infect Dis"},{"key":"R30-17-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.135.3.291","article-title":"Is interleukin 6 an early marker of injury severity following major trauma in humans?","volume":"135","author":"Gebhard","year":"2000","journal-title":"Arch Surg"},{"key":"R31-17-20210128","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00134-005-2787-x","article-title":"A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis","volume":"31","author":"Carrol","year":"2005","journal-title":"Intensive Care Med"},{"key":"R32-17-20210128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0305-4179(96)00124-6","article-title":"Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF\u03b1 and endotoxin levels early after thermal injury","volume":"23","author":"Carsin","year":"1997","journal-title":"Burns"},{"key":"R33-17-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/505504","article-title":"IL6-174 G\/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil","volume":"194","author":"Castellucci","year":"2006","journal-title":"J Infect Dis"},{"key":"R34-17-20210128","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.leu.2403922","article-title":"Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia","volume":"19","author":"Lehrnbecher","year":"2005","journal-title":"Leukemia"},{"key":"R35-17-20210128","doi-asserted-by":"crossref","first-page":"R269","DOI":"10.1152\/ajpregu.1998.275.1.R269","article-title":"Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice","volume":"275","author":"Leon","year":"1998","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R36-17-20210128","doi-asserted-by":"crossref","first-page":"R1013","DOI":"10.1152\/ajpregu.2001.281.3.R1013","article-title":"Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice","volume":"281","author":"Wang","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R37-17-20210128","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1097\/01.CCM.0000240229.98275.07","article-title":"Sepsis-induced cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular regeneration are enhanced in interleukin-6\u2212\/\u2212 mice","volume":"34","author":"Deutschman","year":"2006","journal-title":"Crit Care Med"},{"key":"R38-17-20210128","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1128\/IAI.73.5.2751-2757.2005","article-title":"Role of interleukin-6 in mortality from and physiologic response to sepsis","volume":"73","author":"Remick","year":"2005","journal-title":"Infect Immun"},{"key":"R39-17-20210128","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00436-002-0674-8","article-title":"Do interleukin-6 and macrophage-migration inhibitory factor play a role during sex-associated susceptibility in murine cysticercosis?","volume":"88","author":"Morales-Montor","year":"2002","journal-title":"Parasitol Res"},{"key":"R40-17-20210128","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.4049\/jimmunol.167.8.4527","article-title":"Immunoendocrine interactions during chronic cysticercosis determine male mouse feminization: role of IL-6","volume":"167","author":"Morales-Montor","year":"2001","journal-title":"J Immunol"},{"key":"R41-17-20210128","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J Exp Med"},{"key":"R42-17-20210128","doi-asserted-by":"crossref","first-page":"12075","DOI":"10.1073\/pnas.0605212103","article-title":"ITK and IL-15 support two distinct subsets of CD8+ T cells","volume":"103","author":"Dubois","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R43-17-20210128","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1073\/pnas.0506180103","article-title":"Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite","volume":"103","author":"Combe","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R44-17-20210128","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1128\/IAI.72.11.6729-6732.2004","article-title":"Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii","volume":"72","author":"Lieberman","year":"2004","journal-title":"Infect Immun"},{"key":"R45-17-20210128","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1086\/444393","article-title":"Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium","volume":"192","author":"Dann","year":"2005","journal-title":"J Infect Dis"},{"key":"R46-17-20210128","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.4049\/jimmunol.168.10.4827","article-title":"Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells","volume":"168","author":"Schluns","year":"2002","journal-title":"J Immunol"},{"key":"R47-17-20210128","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.20020369","article-title":"Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells","volume":"195","author":"Becker","year":"2002","journal-title":"J Exp Med"},{"key":"R48-17-20210128","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.4049\/jimmunol.173.4.2705","article-title":"IL-15-independent proliferative renewal of memory CD8+ T cells in latent gammaherpesvirus infection","volume":"173","author":"Obar","year":"2004","journal-title":"J Immunol"},{"key":"R49-17-20210128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1073\/pnas.0609954104","article-title":"A functional SNP of interferon-\u03b3 gene is important for interferon-\u03b1-induced and spontaneous recovery from hepatitis C virus infection","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R50-17-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tube.2004.09.011","article-title":"Control of human host immunity to mycobacteria","volume":"85","author":"Ottenhoff","year":"2005","journal-title":"Tuberculosis"},{"key":"R51-17-20210128","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00431-005-1689-9","article-title":"Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection","volume":"164","author":"Mansouri","year":"2005","journal-title":"Eur J Pediatr"},{"key":"R52-17-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.bmt.1705399","article-title":"Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-\u03b3 receptor 1 deficiency","volume":"38","author":"Chantrain","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R53-17-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000088682","article-title":"Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFN\u03b3R1 deficiency","volume":"73","author":"Remiszewski","year":"2006","journal-title":"Respiration"},{"key":"R54-17-20210128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1348-0421.2004.tb03474.x","article-title":"Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori Infection","volume":"48","author":"Yamamoto","year":"2004","journal-title":"Microbiol Immunol"},{"key":"R55-17-20210128","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64145-4","article-title":"Immunopathology and ehrlichial propagation are regulated by Interferon-\u03b3 and Interleukin-10 in a murine model of human granulocytic ehrlichiosis","volume":"158","author":"Martin","year":"2001","journal-title":"Am J Pathol"},{"key":"R56-17-20210128","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature05762","article-title":"Herpesvirus latency confers symbiotic protection from bacterial infection","volume":"447","author":"Barton","year":"2007","journal-title":"Nature"},{"key":"R57-17-20210128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity","volume":"13","author":"Trinchieri","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"R58-17-20210128","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/eji.200324343","article-title":"IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor \u03b21 deficiency","volume":"33","author":"Hoeve","year":"2003","journal-title":"Eur J Immunol"},{"key":"R59-17-20210128","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23 producing type-1 macrophages promote but IL-10 producing type-2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R60-17-20210128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/eji.200535239","article-title":"Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells","volume":"36","author":"Hoeve","year":"2006","journal-title":"Eur J Immunol"},{"key":"R61-17-20210128","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"R62-17-20210128","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.micinf.2005.10.032","article-title":"Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12\/IL-23 dependent signaling that affect innate and adaptive immunity","volume":"8","author":"Van de Vosse","year":"2006","journal-title":"Microbes Infect"},{"key":"R63-17-20210128","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.inf.0000258696.64507.0f","article-title":"A case of interleukin-12 receptor \u03b2-1 deficiency with recurrent Leishmaniasis","volume":"26","author":"Sanal","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R64-17-20210128","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.175.2.788","article-title":"IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-\u03b3 responses if IL-12p70 is available","volume":"175","author":"Khader","year":"2005","journal-title":"J Immunol"},{"key":"R65-17-20210128","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1128\/IAI.00621-06","article-title":"Neutralization or absence of the interleukin -23 pathway does not compromise immunity to mycobacterial infection","volume":"74","author":"Chackerian","year":"2006","journal-title":"Infect Immun"},{"key":"R66-17-20210128","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.4049\/jimmunol.167.9.5304","article-title":"IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis","volume":"167","author":"Lehmann","year":"2001","journal-title":"J Immunol"},{"key":"R67-17-20210128","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.4049\/jimmunol.167.12.6957","article-title":"A protective and agonistic function of IL-12p40 in mycobacterial infection","volume":"167","author":"Holscher","year":"2001","journal-title":"J Immunol"},{"key":"R68-17-20210128","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1128\/IAI.67.12.6242-6248.1999","article-title":"Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections","volume":"67","author":"Dybing","year":"1999","journal-title":"Infect Immun"},{"key":"R69-17-20210128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ilar.47.2.141","article-title":"Microbial considerations in genetically engineered mouse research","volume":"47","author":"Franklin","year":"2006","journal-title":"ILAR J"},{"key":"R70-17-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jlb.50.5.495","article-title":"Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis","volume":"50","author":"Denis","year":"1991","journal-title":"J Leukoc Biol"},{"key":"R71-17-20210128","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/517519","article-title":"Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis","volume":"195","author":"Plessner","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3282f05c6d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:50:00Z","timestamp":1786035000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200711000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282f05c6d","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}